封面图片，第 44 卷第 2 期

IF 10.9 1区医学 Q1 CHEMISTRY, MEDICINAL

Medicinal Research Reviews Pub Date : 2024-02-05 DOI:10.1002/med.22028

Kang Wang, Yuecan Zhang, Guangji Wang, Haiping Hao, Hong Wang

{"title":"封面图片，第 44 卷第 2 期","authors":"Kang Wang, Yuecan Zhang, Guangji Wang, Haiping Hao, Hong Wang","doi":"10.1002/med.22028","DOIUrl":null,"url":null,"abstract":"<p>The cover image is based on the Review Article <i>FXR agonists for MASH therapy: Lessons and perspectives from obeticholic acid</i> by Kang Wang et al., https://doi.org/10.1002/med.21991\n \n <figure>\n <div><picture>\n <source></source></picture><p></p>\n </div>\n </figure>\n </p>","PeriodicalId":207,"journal":{"name":"Medicinal Research Reviews","volume":"44 2","pages":"i"},"PeriodicalIF":10.9000,"publicationDate":"2024-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/med.22028","citationCount":"0","resultStr":"{\"title\":\"Front Cover Image, Volume 44, Issue 2\",\"authors\":\"Kang Wang, Yuecan Zhang, Guangji Wang, Haiping Hao, Hong Wang\",\"doi\":\"10.1002/med.22028\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The cover image is based on the Review Article <i>FXR agonists for MASH therapy: Lessons and perspectives from obeticholic acid</i> by Kang Wang et al., https://doi.org/10.1002/med.21991\\n \\n <figure>\\n <div><picture>\\n <source></source></picture><p></p>\\n </div>\\n </figure>\\n </p>\",\"PeriodicalId\":207,\"journal\":{\"name\":\"Medicinal Research Reviews\",\"volume\":\"44 2\",\"pages\":\"i\"},\"PeriodicalIF\":10.9000,\"publicationDate\":\"2024-02-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/med.22028\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicinal Research Reviews\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/med.22028\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicinal Research Reviews","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/med.22028","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}

引用次数: 0

摘要

封面图片基于王康等人撰写的评论文章《用于 MASH 治疗的 FXR 激动剂》：王康等人从奥贝胆酸中汲取的教训与展望》，https://doi.org/10.1002/med.21991

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Front Cover Image, Volume 44, Issue 2

查看原文本刊更多论文

Front Cover Image, Volume 44, Issue 2

The cover image is based on the Review Article FXR agonists for MASH therapy: Lessons and perspectives from obeticholic acid by Kang Wang et al., https://doi.org/10.1002/med.21991

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Medicinal Research Reviews 医学-药学

CiteScore

29.30

自引率

0.00%

发文量

审稿时长

2 months

期刊介绍： Medicinal Research Reviews is dedicated to publishing timely and critical reviews, as well as opinion-based articles, covering a broad spectrum of topics related to medicinal research. These contributions are authored by individuals who have made significant advancements in the field. Encompassing a wide range of subjects, suitable topics include, but are not limited to, the underlying pathophysiology of crucial diseases and disease vectors, therapeutic approaches for diverse medical conditions, properties of molecular targets for therapeutic agents, innovative methodologies facilitating therapy discovery, genomics and proteomics, structure-activity correlations of drug series, development of new imaging and diagnostic tools, drug metabolism, drug delivery, and comprehensive examinations of the chemical, pharmacological, pharmacokinetic, pharmacodynamic, and clinical characteristics of significant drugs.